Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia.


Journal

Oncogenesis
ISSN: 2157-9024
Titre abrégé: Oncogenesis
Pays: United States
ID NLM: 101580004

Informations de publication

Date de publication:
16 Jul 2019
Historique:
received: 12 05 2017
accepted: 31 05 2019
revised: 10 04 2019
entrez: 18 7 2019
pubmed: 18 7 2019
medline: 18 7 2019
Statut: epublish

Résumé

Autophagy is associated with both survival and cell death in myeloid malignancies. Therefore, deciphering its role in different genetically defined subtypes of acute myeloid leukemia (AML) is critical. Activating mutations of the KIT receptor tyrosine kinase are frequently detected in core-binding factor AML and are associated with a greater risk of relapse. Herein, we report that basal autophagy was significantly increased by the KIT

Identifiants

pubmed: 31311917
doi: 10.1038/s41389-019-0148-9
pii: 10.1038/s41389-019-0148-9
pmc: PMC6635375
doi:

Types de publication

Journal Article

Langues

eng

Pagination

39

Références

Cancer Discov. 2013 Nov;3(11):1272-85
pubmed: 23965987
Blood. 2010 Sep 30;116(13):2324-31
pubmed: 20574048
Haematologica. 2013 Sep;98(9):1335-43
pubmed: 24006406
Blood. 2015 Sep 10;126(11):1346-56
pubmed: 26186940
Int J Cancer. 2014 Feb 15;134(4):997-1007
pubmed: 23934972
Mol Cell Biol. 2007 Jan;27(1):267-82
pubmed: 17060458
Science. 2009 Feb 6;323(5915):793-7
pubmed: 19131594
Mol Cell. 2015 Jul 16;59(2):285-97
pubmed: 26118643
N Engl J Med. 2016 Jun 30;374(26):2530-41
pubmed: 27355533
N Engl J Med. 2013 Feb 14;368(7):651-62
pubmed: 23406030
EMBO J. 2000 Nov 1;19(21):5720-8
pubmed: 11060023
Clin Cancer Res. 2014 May 1;20(9):2400-9
pubmed: 24610825
Cancer Discov. 2014 Aug;4(8):914-27
pubmed: 24875857
Blood. 2013 Nov 14;122(20):3521-32
pubmed: 24014241
Cell Death Dis. 2014 Feb 27;5:e1088
pubmed: 24577086
FASEB J. 2005 Aug;19(10):1296-8
pubmed: 15919761
Blood. 2017 Feb 2;129(5):547-552
pubmed: 27956388
J Biol Chem. 2013 Oct 25;288(43):31280-8
pubmed: 24019511
J Biol Chem. 2011 Feb 25;286(8):5956-66
pubmed: 21135090
Nat Rev Cancer. 2005 Sep;5(9):726-34
pubmed: 16148885
Autophagy. 2015;11(5):729-39
pubmed: 25951043
Cell Stem Cell. 2016 Jul 7;19(1):23-37
pubmed: 27374788
J Clin Invest. 2003 Dec;112(12):1809-20
pubmed: 14638851
Blood. 2016 Sep 1;128(9):1260-9
pubmed: 27268264
Cell. 2014 Dec 4;159(6):1263-76
pubmed: 25480292
J Clin Oncol. 2006 Aug 20;24(24):3904-11
pubmed: 16921041
Oncogene. 2011 Apr 21;30(16):1855-67
pubmed: 21151168
Cancer Discov. 2017 Jul;7(7):716-735
pubmed: 28416471
Curr Hematol Malig Rep. 2009 Apr;4(2):77-82
pubmed: 20425418
Nat Cell Biol. 2014 Nov;16(11):1069-79
pubmed: 25327288
Cell Death Dis. 2017 Jul 13;8(7):e2927
pubmed: 28703806
Genes Dev. 2011 Mar 1;25(5):460-70
pubmed: 21317241
Oncogene. 2005 May 12;24(21):3397-408
pubmed: 15735721
Oncotarget. 2015 Oct 6;6(30):30149-64
pubmed: 26338968
Cancer Res. 2011 May 1;71(9):3182-8
pubmed: 21521803
Oncogene. 2018 Feb 8;37(6):787-797
pubmed: 29059168
Mol Cell Biol. 1997 Nov;17(11):6508-16
pubmed: 9343414
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15077-82
pubmed: 14657337
Semin Cancer Biol. 2013 Oct;23(5):361-79
pubmed: 23811268
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2450-5
pubmed: 21262832
J Clin Invest. 2009 May;119(5):1109-23
pubmed: 19363292
Blood. 2016 Sep 22;128(12):1614-24
pubmed: 27480114
Blood. 2013 Oct 3;122(14):2467-76
pubmed: 23970379
J Biol Chem. 1999 Oct 22;274(43):31055-61
pubmed: 10521505
Mol Cell. 2012 Dec 14;48(5):667-80
pubmed: 23084476
Autophagy. 2016 Jul 2;12(7):1129-52
pubmed: 27163161
Blood. 2016 Feb 18;127(7):882-92
pubmed: 26286850
Cancer Discov. 2015 Apr;5(4):410-23
pubmed: 25673642
J Clin Invest. 2010 Jan;120(1):142-56
pubmed: 20038799
Med Sci (Paris). 2017 Mar;33(3):328-334
pubmed: 28367821
Nat Cell Biol. 2013 Jul;15(7):713-20
pubmed: 23817233
Cell Death Dis. 2013 Feb 07;4:e485
pubmed: 23392173
Cell Signal. 2014 May;26(5):917-24
pubmed: 24462646
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7031-6
pubmed: 22509024
Tumour Biol. 2014 Jul;35(7):7097-103
pubmed: 24760274
Nat Chem Biol. 2014 Dec;10(12):1013-9
pubmed: 25326666

Auteurs

Clément Larrue (C)

Cancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
University of Toulouse, Toulouse, France.

Quentin Heydt (Q)

Cancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
University of Toulouse, Toulouse, France.

Estelle Saland (E)

Cancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
University of Toulouse, Toulouse, France.

Héléna Boutzen (H)

Cancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
University of Toulouse, Toulouse, France.

Tony Kaoma (T)

Proteome and Genome Research Unit, Department of Oncology, Luxembourg Institute of Health, Strassen, Luxembourg.

Jean-Emmanuel Sarry (JE)

Cancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
University of Toulouse, Toulouse, France.

Carine Joffre (C)

Cancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France.
University of Toulouse, Toulouse, France.

Christian Récher (C)

Cancer Research Center of Toulouse (CRCT), UMR1037 INSERM, ERL5294 CNRS, Equipe Labellisée LIGUE, Toulouse, France. recher.christian@iuct-oncopole.fr.
University of Toulouse, Toulouse, France. recher.christian@iuct-oncopole.fr.
Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France. recher.christian@iuct-oncopole.fr.

Classifications MeSH